Director Stacy Durbin Nieuwoudt filed a Form 4 with the SEC on November 6, 2026, disclosing the acquisition of restricted stock units and stock options in Aspen Aerogels Inc (NYSE:ASPN) on November 4, 2026, as part of the company's annual non-employee director equity grant.

Key Highlights

  • RSU grant: Nieuwoudt acquired 6,073 restricted stock units at a price of $0.00, representing a portion of the annual director equity grant.
  • Stock options granted: Nieuwoudt also received 5,100 stock options with an exercise price of $4.80, acquired at $0.00, as the remaining portion of the annual grant.
  • Transaction date: Both grants were made on November 4, 2026.
  • Vesting schedule: Both the RSUs and options vest on the earlier of May 13, 2027, or the day prior to the issuer's 2027 annual meeting of stockholders.
  • Post-transaction ownership: Following the transaction, Nieuwoudt directly holds 6,073 shares of common stock and 5,100 derivative securities (stock options).
  • Relationship to issuer: Nieuwoudt is identified in the filing as a director of Aspen Aerogels Inc.

Annual Director Equity Award Details for Nieuwoudt at Aspen Aerogels

According to the filing, Stacy Durbin Nieuwoudt, a director of Aspen Aerogels Inc, received two equity awards on November 4, 2026, under the issuer's Non-Employee Director Compensation Policy. The first award consisted of 6,073 restricted stock units, each representing the right to receive one share of common stock upon vesting, acquired at no cost to the reporting person. The filing describes this grant as "a portion of the annual grant of equity for service as a non-employee director."

The second award consisted of 5,100 stock options (rights to buy common stock) with an exercise price of $4.80, also acquired at $0.00, representing "the remaining portion of the annual grant of equity for service as a non-employee director," according to the filing. The options have an expiration date of November 4, 2036, as stated in Table II of the form.

Both awards are subject to the same vesting condition: they vest on the earlier of May 13, 2027, or the day prior to the issuer's annual meeting of stockholders to be held in 2027. Following the reported transactions, Nieuwoudt directly holds 6,073 shares of common stock and 5,100 stock options. The Form 4 was signed by Glenn Deegan as Attorney-in-Fact and filed on November 6, 2026.

What Was Disclosed

The filing disclosed two equity awards granted to director Stacy Durbin Nieuwoudt on November 4, 2026: 6,073 RSUs and 5,100 stock options with a $4.80 exercise price, both granted under Aspen Aerogels' Non-Employee Director Compensation Policy and vesting no later than May 13, 2027.